HHealthcare Read More Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?November 12, 2025 Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
HHealthcare Read More Three Healthcare Buys That Wall Street LovesNovember 11, 2025 Healthcare stocks are hot right now. Several factors are driving them higher, including innovations in areas like heart…
HHealthcare Read More 3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 DrugsNovember 10, 2025 Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…
MMedication Read More Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharmaNovember 8, 2025 New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
MMedication Read More Weight loss gets cheaper: New White House deal slashes prices of Ozempic and Wegovy |November 6, 2025 The cost of some of the most widely used weight loss medications in the United States is set…
MMedication Read More Weight-Loss Drug Zepbound Gets Walmart D2C PricingNovember 5, 2025 Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…
HHealthcare Read More Is Eli Lilly a Millionaire Maker?November 5, 2025 Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
MMedication Read More Massive sales for weight loss drugs spur Eli Lilly’s Q3October 31, 2025 As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
MMedication Read More Eli Lilly says weight-loss pill a candidate for speedy approval under new US programOctober 31, 2025 By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…
HHealthcare Read More Lilly invests in epigenetic reprogramming biotechOctober 23, 2025 NewLimit adds $45m in new funding at a $1.6bn valuation following preclinical progress that brings clinical trials closer…
MMedication Read More Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechangerOctober 18, 2025 Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
MMedication Read More Warning after ‘King Kong’ of weight-loss jabs found being sold illegally on social mediaOctober 17, 2025 Fake versions of highly sought-after weight-loss jabs are being sold illegally on social media, an investigation has found.…